Taysha Gene Therapies Inc (TSHA)

$2.97 0.02 (0.67%)

16:00 EDT TSHA Stock Quote Delayed 30 Minutes

3 Small-Cap Stocks to Sell in September Before They Crash & Burn

By Ian Bezek, InvestorPlace Contributor Sep 4, 2023

A lot of speculative companies enjoyed strong rallies in the summer. Sell these three small-cap stocks before it's too late.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap 191.46M

PE Ratio -1.29

EPS -2.31

Volume (Avg. Vol.) 852,895

Day's Range $2.92 - $3.04

52-Week Range $0.50 - $3.89

Dividend & Yield N/A (N/A)

TSHA Stock Predictions, Articles, and Taysha Gene Therapies Inc News

From InvestorPlace
From the Web

What Is Going on With Taysha Gene (TSHA) Stock Today?

By Dana Blankenhorn, InvestorPlace Contributor Oct 25, 2022

Taysha and its new partner Astellas are both speculating that Adeno Associated Viruses can create treatments for genetic diseases.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Oct 25, 2022

We're starting off the day with an overview of the biggest pre-market stock movers on Tuesday and the latest news this morning!

Biggest stock movers today: Instacart, ARS Pharmaceuticals and more

From Seeking Alpha Sep 20, 2023

Stock futures are trading near the flatline in the early hours of Wednesday as market players prepare for the second day of the Fed&amp;#39;s policy meeting.Here are some of Wednesd

Taysha Gene Therapies ceases development of neurology drug TSHA-120 (TSHA)

From Seeking Alpha Sep 19, 2023

Taysha Gene Therapies (TSHA) is discontinuing development of its drug candidate TSHA-120 for the treatment of giant axonal neuropathy due to study design problems. Read more here.

2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?

From The Motley Fool Sep 19, 2023

These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?

AAOI, COXS and HROW are among after hour movers (NASDAQ:TSHA)

From Seeking Alpha Aug 14, 2023

Gainers: Taysha Gene Therapies (TSHA) +12%. Arcellx (ACLX) +10%

Taysha Gene Therapies (TSHA) Gets a Buy from JMP Securities

From TipRanks Nov 10, 2022

In a report released today, Silvan Tuerkcan from JMP Securities maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report), with a price target...

Robert W. Baird Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)

From TipRanks Nov 10, 2022

Robert W. Baird analyst Jack Allen maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report) on November 8 and set a price target of $21.00. T...